Zai Lab at a glance
As of- [1] Equity raised: Sum of the 1 sourced equity round in the funding history below (debt, tender offers and rumored rounds excluded), October 23, 2026
Is this your company? Get featured or correct your listing →
Recent changes
- Oct 25, 2026Oct 25, 2026Zai Lab's $250M PIPE Shows How Biotechs Refill Pipelines Pulse story
- Oct 23, 2026Oct 23, 2026Raised $250M Pulse 2.0
- Oct 23, 2026Oct 23, 2026New investor: Frazier Life Sciences Pulse 2.0
- Oct 23, 2026Oct 23, 2026New investor: Wellington Management Pulse 2.0
- Oct 23, 2026Oct 23, 2026New investor: RTW Investments Pulse 2.0
Earlier changes (3)
- Oct 23, 2026Oct 23, 2026New investor: RA Capital Pulse 2.0
- Oct 23, 2026Oct 23, 2026New investor: Cormorant Asset Management Pulse 2.0
- Oct 23, 2026Oct 23, 2026Zai Lab Raises $250M PIPE For DLL3 Cancer Drug Pulse story
Funding history
1 equity event · newest first · sources dated per row| Date | Round | Amount | Valuation | Lead investors | Source |
|---|---|---|---|---|---|
| Oct 23, 2026 | Funding round | $250M | — | — WithCormorant Asset ManagementunverifiedFrazier Life SciencesunverifiedRA CapitalunverifiedRTW InvestmentsunverifiedWellington ManagementunverifiedWorld Healthcare FundADAR1 Capital ManagementBalyasny Asset ManagementSirenia Capital Management+1 more | Pulse 2.0 |
Equity only. “Equity raised” above sums the rounds with a dated, linked source; rumored rounds, tender offers and secondary sales are listed but not counted, and debt financing is listed separately.
Investors
Latest Pulse
- Oct 26, 2026Biotechs Keep Pricing IPOs While AI Mega-Valuations WobbleLycia Therapeutics priced an upsized $317.5M IPO and Zai Lab raised $250M in a PIPE the same week Anthropic's leaked prospectus showed a $42B net loss -- biotech's IPO window still works even as AI mega-valuations get harder to price.→
- Oct 25, 2026Zai Lab's $250M PIPE Shows How Biotechs Refill PipelinesNasdaq-listed Zai Lab raised about $250 million in a PIPE financing, selling 11.34 million shares at $22.04 each to fund its DLL3-targeting cancer drug, a reminder that public biotechs still lean on private placements between launches.→
- Oct 25, 2026Biotech's AI Bet: $687M Across Three Rounds In One WeekThree biotech financings announced in the same week pushed $687 million into AI-linked drug development, with OrbiMed and Janus Henderson among the investors doubling down on the sector.→
- Oct 23, 2026Zai Lab Raises $250M PIPE For DLL3 Cancer DrugAs of October 23, 2026, Nasdaq-listed Zai Lab has raised about $250 million in a PIPE financing, selling 11.34 million ADSs at $22.04 each to fund its DLL3-targeting antibody-drug conjugate, zocilurtatug pelitecan.→
Coverage Timeline
newest firstAll Coverage
IPO
Biotechs Keep Pricing IPOs While AI Mega-Valuations Wobble
Lycia Therapeutics priced an upsized $317.5M IPO and Zai Lab raised $250M in a PIPE the same week Anthropic's leaked prospectus showed a $42B net loss -- biotech's IPO window still works even as AI mega-valuations get harder to price.
BY THE NUMBERS
Zai Lab's $250M PIPE Shows How Biotechs Refill Pipelines
IPO$250M PIPE
Zai Lab's $250M PIPE Shows How Biotechs Refill Pipelines
Nasdaq-listed Zai Lab raised about $250 million in a PIPE financing, selling 11.34 million shares at $22.04 each to fund its DLL3-targeting cancer drug, a reminder that public biotechs still lean on private placements between launches.
DEEP DIVE
Zai Lab Raises $250M PIPE For DLL3 Cancer Drug
FUNDING$250M PIPE
Zai Lab Raises $250M PIPE For DLL3 Cancer Drug
As of October 23, 2026, Nasdaq-listed Zai Lab has raised about $250 million in a PIPE financing, selling 11.34 million ADSs at $22.04 each to fund its DLL3-targeting antibody-drug conjugate, zocilurtatug pelitecan.
BY THE NUMBERS
Related Companies
Zai Lab FAQ
How much has Zai Lab raised?
Zai Lab has raised at least $250M in equity across 1 sourced funding round tracked by Value Add VC. The most recent was a $250M funding round in October 2026, reported by Pulse 2.0. Debt financing, tender offers and secondary sales are not counted.
Sources & methodologyshow
Where these figures come from
- Pulse 2.0research database1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.